Anandamide, a natural ligand for the peripheral cannabinoid receptor is a novel synergistic growth factor for hematopoietic cells

Blood

Volumn 90, Issue 4, 1997, Pages 1448-1457

  Valk, Peter ^a   Verbakel, Sandra ^a   Vankan, Yolanda ^a   Hol, Samantha ^a   Mancham, Shanta ^a   Ploemacher, Rob ^a   Mayen, Angelique ^a   Löwenberg, Bob ^a   Delwel, Ruud ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANANDAMIDE; CANNABINOID RECEPTOR; ERYTHROPOIETIN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; INTERLEUKIN 3; LIGAND; MESSENGER RNA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; ERYTHROID CELL; FETAL CALF SERUM; GENE EXPRESSION; HEMATOPOIETIC CELL; LIGAND BINDING; MACROPHAGE; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN; T LYMPHOCYTE; THYMUS;

EID: 0030753167     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.4.1448.1448_1448_1457     Document Type: Article

References (62)

1. Clark SC, Kamen R: The human hematopoietic colony stimulating factors. Science 236:1229, 1987
2. Metcalf D: The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells. Nature 339:27, 1989
3. Bazan JF: Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci USA 87:6934, 1990
4. Gudermann T, Nurnberg B, Schultz G: Receptors and G proteins as primary components of transmembrane signal transduction. Part 1. G-protein-coupled receptors: Structure and function. J Mol Med 73:51, 1995
5. Savarese TM, Fraser CM: In vitro mutagenesis and the search for structure-function relationships among G protein-coupled receptors. Biochem J 283:1, 1992
6. Delwel R, Hol S, Vankan Y, Löwenberg B, Ihle JN, Copeland NG, Valk PJM: The cannabinoid receptor-2 is a potential oncogene in myeloid mouse leukemias. Blood 88:1345, 1996
7. Munro S, Thomas KL, Abu-Shaar M: Molecular characterization of a peripheral receptor for cannabinoids. Nature 365:61, 1993
8. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI: Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:561, 1990
9. Gerard CM, Mollereau C, Vassart G, Parmentier M: Molecular cloning of a human cannabinoid receptor which is also expressed in testis. Biochem J 279:129, 1991
10. Greenberger JS, Sakaakeeny MA, Humphries RK, Eaves CJ, Eckner RJ: Demonstration of permanent factor-dependent multipotential (erythroid/neutrophil/basophil) hematopoietic progenitor cell lines. Proc Natl Acad Sci USA 80:2931, 1983
11. Migliaccio G, Migliaccio AR, Kreider BL, Rovera G, Adamson JW: Selection of lineage-restricted cell lines immortalized at different stages of hematopoietic differentiation from the murine cell line 32D. J Cell Biol 109:833, 1989
12. Ihle JN, Rein A, Mural R: Immunological and virological mechanisms in retroviral induced murine leukemogenesis. Adv Viral Oncol 4:95, 1984
13. Holmes KL, Palaszinsky E, Frederickson TN, Morse HC III, Ihle JN: Correlation of cell-surface phenotype with the establishment of interleukin-3-dependent cell lines from wild-mouse murine leukemia virus-induced neoplasms. Proc Natl Acad Sci USA 82:6687, 1985
14. Buchberg AM, Bedigian HG, Jenkins NA, Copeland NC: Evil2, a common integration site involved in murine myeloid leukemogenesis. Mol Cell Biol 10:4658, 1990
15. Trakhtenbrot L, Krauthgamer R, Resnitzky P, Haran-Ghera N: Deletion of chromosome 2 is an early event in the development of radiation-induced myeloid leukemia in SJL/J mice. Leukemia 2:545, 1988
16. Azumi JI, Sachs L: Chromosome mapping of the genes that control differentiation and malignancy in myeloid leukemic cells. Proc Natl Acad Sci USA 74:253, 1977
17. De Both NJ, Hagenmeijer A, Rhijnsburger EH, Vermey M, Van't Hul E, Smit EME: DMSO induced terminal differentiation and trisomi 15 in myeloid cell line transformed by the Rauscher murine leukemia virus. Cell Differ 10:13, 1981
18. Leenen PJM, Jansen AMAC, van Ewijk W: Murine macrophage cell lines can be ordered in a linear differentiation sequence. Differentiation 32:157, 1986
19. Shen-Ong GLC, Potter M, Mushinsky JF, Lavu S, Reddy EP: Activation of the c-myb locus by viral insertional mutagenesis in plasmacytoid lymphosarcomas. Science 226:1077, 1984
20. Dudek H, Reddy EP: Murine myeloid leukemias with aberrant myb loci show heteroneous expression of novel myb proteins. Oncogene 4:1489, 1989
21. Pierce JH, Di Fiore PP, Aaronson SA, Potter M, Pumphrey J, Scott A, Ihle JN: Neoplastic transformation ofmast cells by AbelsonMuLV: Abrogation of IL-3 dependence by nonautocrine mechanism. Cell 41:685, 1985
22. Raschke WC, Baird S, Ralph P, Nakoinz I: Functional macrophage cell lines transformed by Abelson leukemia virus. Cell 15:261, 1978
23. Ralph P, Prichard J, Cohn M: Reticulum cell sarcoma: An effector cell in antibody-dependent cell mediated immunity. J Immunol 114:898, 1975
24. Ralph P, Ho M-K, Litcofsky PB, Springer TA: Expression and induction in vitro of macrophage differentiation antigens on murine cell lines. J Immunol 130:108, 1983
25. Warner NL, Moore MAS, Metcalf D: A transplantable myelomonocytic leukemia in BALB/c mice: Cytology, karyotype and muramidase content. J Natl Cancer Inst 43:963, 1969
26. Hagemeijer A, Smit EME, Govers F, de Both NJ: Trisomy 15 and other nonrandom chromosome changes in Rauscher murine leukemia virus-induced leukemia cell lines. J Natl Cancer Inst 69:945, 1982
27. Lanier LL, Warner NL: Cell cycle related heterogeneity of Ia antigen expression on a murine B lymphoma cell line: Analysis by flow cytometry. J Immunol 126:626, 1981
28. Warner NL, Daley MJ, Richey J, Spellman C: Flow cytometry analysis of murine B cell lymphoma differentiation. Immunol Rev 48:197, 1979
29. Palacios R, Steinmetz M: IL-3 dependent mouse clones that express B-220 surface antigen, contain Ig genes in germline configuration, and generate B-lymphocytes in vivo. Cell 41:727, 1985
30. Decleve A, Lieberman M, Ihle JN, Rosenthal NPN, Lung ML, Kaplan HS: Physiochemical, biological and serological properties of a leukemogeneic virus isolated from cultured RadLV-induced lymphomas of C57BL/Ka mice. Virology 90:23, 1978
31. Harris AW, Bankhurst AD, Mason S, Warner NL: Differentiated functions expressed by cultured mouse lymphoma cells. II. Theta antigen, surface immunoglobulin and a receptor for antibody on cells of a thymoma cell line. J Immunol 110:431, 1973
32. Ichikawa Y: Differentiation of a cell line of myeloid leukemia. J Cell Physiol 74:223, 1969
33. Koren HS, Handwerger BS, Wunderlich JR: Identification of macrophage-like characteristics in a cultured murine tumor line. J Immunol 114:894, 1975
34. Shevach EM, Stobo JD, Green I: Immunoglobin and thetabearing murine leukemias and lymphomas. J Immunol 108:1146, 1972
35. Gillis S, Smith KA: Long term culture of tumour-specific cytotoxic T cells. Nature 268:154, 1977
36. Dong F, Van Buitenen C, Pouwels K, Hoefsloot LH, Löwenberg B, Touw IP: Distinct cytoplasmic regions of the human granulocyte colony-stimulating factor receptor involved in induction of proliferation and maturation. Mol Cell Biol 13:7774, 1993
37. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual (ed 2). Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1989
38. Salem M, Delwel R, Touw I, Mahmoud L, Löwenberg B: Human AML colony growth in serum-free culture. Leuk Res 12:157, 1988
39. Ploemacher RE, van Soest PL, Boudewijn A: Autocrine transforming growth factor β1 blocks colony formation and progenitor cell generation by hematopoietic cells stimulated with steel factor. Stem Cells 11:336, 1993
40. Ploemacher RE, van Soest PL, Voorwinden H, Boudewijn A: Interleukin-12 synergizes with interleukin-3 and steel factor to enhance recovery of murine hemopoietic stem cells in liquid culture. Leukemia 7:1381, 1993
41. Kaminsky NE, Abood AE, Kessler FK, Martin BR, Schatz AR: Identification of a functional relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation. Mol Pharmacol 42:736, 1992
42. Lynn AB, Herkenham M: Localization of cannabinoid receptors and nonsaturable high density cannabinoid binding sites in peripheral tissues of the rat: Implications for receptor mediated immune modulation by cannabinoids. J Pharmacol Exp Ther 268:1612, 1994
43. Bouaboula M, Rinaldi M, Carayon P, Carillon C, Delpech B, Shire D, Le Fur G, Casellas P: Cannabinoid-receptor expression in human leukocytes. Eur J Biochem 214:173, 1993
44. Facci. L, Dal Toso R, Buriani A, Skaper SD, Leon A: Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc Natl Acad Sci USA 92:3376, 1995
45. Schwarz H, Blanco FJ, Lotz M: Anandamide, an endogenous cannabinoid receptor agonist inhibits lymphocyte proliferation and induces apoptosis. J Neuroimmunol 55:107, 1994
46. Daaka Y, Klein TW, Friedman H: Expression of cannabinoid receptor mRNA in murine and human leukocytes, in Sharp B (ed): The Brain Immune Axis and Substance Abuse, Vol 13. New York, NY, Plenum, 1995, p 91
47. Barg J, Fride E, Hanus L, Levy R, Matus-Leibovitch N, Heldman E, Bayewitch M, Mechoulam R, Vogel Z: Cannabinomimetic behavioral effects of and adenylate cyclase inhibition by two new edogenous anandamides. Eur J Pharmacol 287:145, 1995
48. Lee M, Yang KH, Kaminski N: Effects of putative cannabinoid receptor ligands, anandamide and 2-arachidonyl-glycerol, on immune function in B6C3F1 mouse splenocytes. J Pharmacol Exp Ther 275:529, 1995
49. Shire D, Calandra B, Rinaldi-Carmona M, Oustric D, Pessegue B, Bonnin-Cabanne O, Le Fur G, Caput D, Ferrara P: Molecular cloning, expression and function of the murine Cb2 peripheral cannabinoid receptor. Biochem Biophys Acta 1307:132, 1996
50. Slipetz DM, O'Neal GP, Favreau L, Dufresne C, Gallant M, Gareau Y, Guay D, Labelle M, Metters KM: Activation of the human peripheral cannabinoid receptor results in inhibition of adenylyl-cyclase. Mol Pharmacol 48:352, 1995
51. Felder CC, Veluz JS, Williams HL, Briley EM, Matsuda LA: Cannabinoid agonists stimulate both receptor-and nonreceptor-mediated signal transduction pathways in cells transfected with and expressing cannabinoid receptor clones. Mol Pharmacol 42:838, 1992
52. Nicholson SE, Gates AC, Harpur AG, Ziemiecki A, Wilks AF, Layton JE: Tyrosin kinase Jak1 is associated with the granulocyte-colony-stimulating factor receptor and both become tyrosine phosphorylated after receptor activation. Proc Natl Acad Sci USA 91:2985, 1994
53. Tian SS, Lamb P, Seidel AM, Stein RB, Rosen J: Rapid activation of the STAT3 transcription factor by granulocyte colony stimulating factor. Blood 84:1760, 1994
54. ras/MAP kinase signalling pathway. Blood 83:949, 1994
55. Daub H, Weiss FU, Wallasch C, Ullrich A: Role of transactivation of the receptor in signalling by G-protein-coupled receptors. Nature 379:557, 1996
56. 1 receptor. Nature 375:247, 1995
57. Wartmann M, Campbell D, Subramanian A, Burstein SH, Davis RJ: The MAP kinase signal transduction pathway is activated by the endogenous cannabinoid anandamide. FEBS Lett 359:133, 1995
58. Bouaboula M, Poinot-Chazel C, Bourrie B, Canat X, Calandra B, Rinaldi-Carmona M, Le Fur G, Casellas P: Activation of mitogen activated protein kinase by stimulation of the central cannabinoid receptor Cb1. Biochem J 312:637, 1995
59. Bouaboula M, Bourrie B, Rinaldi-Carmona M, Shire D, Le Fur G, Casellas P: Stimulation of cannabinoid receptor Cb1 induces Krox-24 expression in human Astroma cells. J Biol Chem 270:13973, 1995
60. Bouaboula M, Poinot-Chazel C, Marchand J, Canat X, Bourrie B, Rinaldi-Carmona M, Calandra B, Le Fur G, Casellas P: Signalling pathway associated with stimulation of Cb2 peripheral cannabinoid receptor. Involvement of both mitogen-activated kinase and induction of Krox-24 expression. Eur J Biochem 237:704, 1996
61. kip1) of cyclin dependent kinase 4 activation. Cell 79:487, 1994
62. Van Biesen T, Hawes BE, Luttrell DK, Krueger KM, Touhara K, Porfiri E, Sakaue M, Luttrell LM, Lefkowitz RJ: Receptor-tyrosine-kinase-and G-mediated MAP kinase activation by a common signalling pathway. Nature 376:781, 1995